GlassScriptPhysician profile
Philip J Citek
NPI 1275633232
$591.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $183 · 2021: $57.53 · 2022: $20.57 · 2023: $16.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $238.50 | 2019-2020 | |
| Pfizer INC. | $155.12 | 2019-2020 | |
| Boston Scientific Corporation | $57.82 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $22.80 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $22.61 | 2020 | |
| Grt US Holding, INC. | $20.57 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $16.39 | 2023 | Firdapse |
| Bioventus LLC | $15.52 | 2019 | |
| Medtronic, INC. | $14.24 | 2021 | |
| Lundbeck LLC | $14.06 | 2020 | |
| Scilex Pharmaceuticals INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Citek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.